Effects of aripiprazole on operant responding for a natural reward after psychostimulant withdrawal in rats

Psychopharmacology

Volumn 191, Issue 3, 2007, Pages 759-765

  Schwabe, Kerstin ^b   Koch, Michael ^a  

^a UNIVERSITY OF BREMEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Addiction; Amphetamine; Breakpoint; Dopamine; Psychostimulant

Indexed keywords

AMPHETAMINE; ARIPIPRAZOLE; DOPAMINE RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; DRUG WITHDRAWAL; FOOD; INSTRUMENTAL CONDITIONING; LOW DRUG DOSE; MALE; MOTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; REWARD; TRAINING;

AMPHETAMINE; ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, OPERANT; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTIVATION; PIPERAZINES; QUINOLONES; RATS; RATS, WISTAR; REINFORCEMENT SCHEDULE; REWARD; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 33847686847     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-006-0520-2     Document Type: Article

References (26)

1. Abermann JE, Ward SJ, Salamone JD (1998) Effects of dopamine antagonists and accumbens dopamine depletion on time-constrained progressive-ratio performance. Pharmacol Biochem Behav 61:341-348
2. Barr AM, Phillips AG (1999) Withdrawal following repeated exposure to d-amphetamine decreases responding for a sucrose solution as measured by a progressive ratio-schedule of reinforcement. Psychopharmacology 141:99-106
3. Barr AM, Markou A, Phillips AG (2002) A 'crash' course on psychostimulant withdrawal as a model of depression. Trends Pharmacol Sci 10:475-482
4. Caul WF, Jones JR, Barrett RJ (1988) Amphetamine's effects on food consumption and body weight: the role of adaptive processes. Behav Neurosci 102:441-450
5. 3 antagonist raclopride on progressive ratio operant responding. Behav Pharmacol 6:127-132
6. Ferguson SA, Paule MG (1996) Effects of chlorpromazine and diazepam on time estimation behavior and motivation in rats. Pharmacol Biochem Behav 53:115-122
7. Grady MA, Gasperoni TL, Kirkpatrick P (2003) Fresh from the pipeline: aripiprazole. Nat Rev Drug Discov 2:427-428
8. Hodos W (1961) Progressive ratio as a measure of reward strength. Science 134:943-944
9. Inoue T, Domae M, Yamada K, Furukawa T (1996) Effects of the novel antipsychotic agent 7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl] butyloxy)-3,4-dihydro-2)1H)-quinolinone (OPC-14597) on prolactine release from the rat anterior pituitary gland. J Pharmacol Exp Ther 277:137-143
10. Kane JM, Carson WH, Saha AR, McQuade RD, Ingenito GG, Zimbroff DL, Ali MW (2002) Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorders. J Clin Psychiatry 63:763-771
11. 2 receptor antagonistic activity. J Pharmacol Exp Ther 274:329-336
12. Lawler CP, Prioleau C, Lewis MM, Mak C, Jiang D, Schetz JA, Gonzales AM, Sibley DR, Mailman RB (1999) Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. Neuropsychopharmacology 136:153-161
13. Markou A, Koob GF (1992) Bromocriptine reverses the elevation in intracranial self-stimulation thresholds observed in a rat model of cocaine withdrawal. Neuropsychopharmacology 7:213-224
14. McGawin JK, Goa KL (2002) Aripiprazole. CNS Drugs 16:779-786
15. Mobini S, Chiang TJ, Ho MY, Bradshaw CM, Szabidi E (2000) Comparison of the effects of clozapine, haloperidol, chlorpromazine and d-amphetamine on performance on a time-constrained progressive ratio schedule and on locomotor behaviour in the rats. Psychopharmacology 152:47-54
16. Orsini CO, Koob GF,Pulvirenti LP (2001) Dopamine partial agonist reverses amphetamine withdrawal in rats. Neuropsychopharmacology 25 789-792
17. Papakostas GI, Petersen TJ, Kinrys G, Burns AM, Worthington JJ, Alpert JE, Fava M, Nierenberg AA (2005) Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder. J Clin Psychiatry 66:1326-1330
18. Pathiraja A, Marazziti D, Cassano GB, Diamond BJ, Borison RL (1995) Phenomenology and neurobiology of cocaine withdrawal: are they related? Prog Neuropsychopharmacol Biol Psychiatry 19:1021-1034
19. Paulson PE, Camp PM, Robinson TE (1991) Time Course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology 103:480-492
20. 3 receptor agonist. Nature 400:371-375
21. Pulvirenti L, Koob GF (1993) Lisuride reduces psychomotor retardation during withdrawal from chronic intravenous amphetamine self-administration in rats. Neuropsychopharmacology 8:213-218
22. Pulvirenti L, Koob GF (2002) Being partial to psychostimulant addiction therapy. Trends Pharmacol Sci 23:151-153
23. Schindler CW, Persico AM, Uhl GR, Goldberg SR (1994) Behavioral assessment of high-dose amphetamine withdrawal: importance of training and testing conditions. Pharmacol Biochem Behav 49:41-46
24. Swerdlow NR, Geyer MA, Braff DL (2001) Neural circuit regulation of prepulse inhibition of startle in rat: current knowledge and future challenge. Psychopharmacology 156:194-215
25. Taylor DM (2003) Aripiprazole: a review of its pharmacology and clinical use. Int J Clin Pract 57:49-54
26. Wise RA, Rompre PP (1982) Neuroleptics and operant behavior: the anhedonia hypothesis. Behav Brain Sci 5:39-87